Search

everythinglearnresearchcommunity

for

Search:↓

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A patient with complete hair loss regrew all her hair using tofacitinib.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Ciproterone acetate improves hair regrowth and acne in most female patients.